Registry for Advanced Sarcodiosis
NCT03769987 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 800
Last updated 2018-12-10
Summary
Registry with evaluation and genetic information of patients with advanced sarcoidosis and matched sarcoidosis
Conditions
- Sarcoidosis
Interventions
- OTHER
-
observation
observe patients every 6 months
Sponsors & Collaborators
-
University of Cincinnati
lead OTHER
Principal Investigators
-
Robert Baughman · University of Cincinnati
Eligibility
- Min Age
- 15 Years
- Max Age
- 100 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2017-01-01
- Primary Completion
- 2019-12-31
- Completion
- 2020-06-30
Countries
- United States
Study Locations
More Related Trials
-
Study of Efficacy, Safety and Tolerability of ACZ885 (Canakinumab) in Patients With Pulmonary Sarcoidosis
NCT02888080 ·Status: COMPLETED ·Phase: PHASE2
-
Lyon Sarcoid Uveitis Cohort
NCT03863782 ·Status: RECRUITING
-
The Longitudinal Evaluation of Autoimmune Pulmonary Alveolar Proteinosis
NCT03531996 ·Status: COMPLETED
-
ACE and HLA Genotypes Predict Severity and Disease Progression in Danish Sarcoid Patients
NCT04462068 ·Status: COMPLETED
-
VCRC Patient Contact Registry Patient-Reported Data Validation Study
NCT02190942 ·Status: COMPLETED
-
CASPA: CArdiac Sarcoidosis in PApworth
NCT03599414 ·Status: COMPLETED
-
Mast Cell Connect: A Registry for Patients With Mastocytosis
NCT02620254 ·Status: COMPLETED
-
Clinical and Genetic Study of Familial Sarcoidosis (SARCFAM)
NCT02829853 ·Status: UNKNOWN
-
Analysis of Bronchial Tissue and Fluid in Patients With Wegener's Granulomatosis
NCT00001541 ·Status: COMPLETED
-
Cardiac Sarcoidosis Randomized Trial
NCT03593759 ·Status: RECRUITING ·Phase: PHASE3
-
SPARC Smartphone Application for the Management of Sarcoidosis-Associated Fatigue
NCT05230693 ·Status: COMPLETED ·Phase: NA
-
Development of a Novel Human In Vitro Sarcoidosis Model
NCT01857401 ·Status: COMPLETED
-
Immunologic Markers for the Differential Diagnosis Between Uveitis-TBC and Uveitis-SARC (TBC-SARC)
NCT03346018 ·Status: COMPLETED
-
Vasculitis Pregnancy Registry
NCT02593565 ·Status: RECRUITING
-
Expression and Role of the JAK/STAT Pathway in Sarcoidosis Granuloma Cells
NCT04751279 ·Status: RECRUITING
-
Neurosarcoidosis : Initial Presentation and Disease Course
NCT04911348 ·Status: UNKNOWN
-
Safety Study of Abatacept to Treat Refractory Sarcoidosis
NCT00739960 ·Status: TERMINATED ·Phase: PHASE2
-
A Registry for Patients With Systemic Mastocytosis in China
NCT06013683 ·Status: RECRUITING
-
Mycophenolate for Pulmonary Sarcoidosis
NCT00262132 ·Status: TERMINATED ·Phase: PHASE3
-
Cell Free DNA in Cardiac Sarcoidosis
NCT03858777 ·Status: RECRUITING ·Phase: NA
-
Pilot Study of Short-Course Glucocorticoids and Rituximab for Treatment of ANCA-Associated Vasculitis
NCT02169219 ·Status: COMPLETED ·Phase: PHASE4
-
Determination of Genetic Susceptibility in Severe Recurrences of Ocular Toxoplasmosis
NCT02863588 ·Status: TERMINATED ·Phase: NA
-
The Serum Angiotensin Converting Enzyme and Lysozyme Levels in Patients Non-infectious and Infectious Uveitis
NCT02627209 ·Status: UNKNOWN ·Phase: NA
-
ACTHAR GEL for Sarcoidosis-Associated Calcium Dysregulation: An Open-label Pilot Study
NCT02155803 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Mastocytosis Registry (of Zurich)
NCT06466889 ·Status: RECRUITING